on Wednesday flagged promising late-stage trial outcomes for its new Cagrilinitide being overweight treatment, given that the Danish pharmaceutical huge seeks a next-era alternative to its blockbuster Wegovy pounds-decline drug.→ Lessen reliance on willpower: Operates with your body’s signaling programs as an alternative to from them.→ Mechan